Abstract:Based on a novel lead compound 4-methylpiperazine-1-carbodithioic acid 3-cyano-3,3-diphenylpropyl ester 1, the systematic structural modification was carried out. All the synthesized compounds were evaluated for their in-vitro anticancer activities on four to six different cell lines at three different concentrations. Most of the tested compounds could selectively inhibit the growth of HL-60 and Bel-7402 cell lines at a medium concentration. Four compounds (3f, 3g, 3n, and 5) were selected for the IC(50) test, and the results revealed that three compounds (3g, 3n, and 5) showed almost the same or a slightly weaker activity than compound 1 against HL-60, and three compounds (3f, 3g, and 3n) showed > 2-fold higher potency than compound 1 against Bel-7402. The in-vivo efficacy of 3n center dot HCl was evaluated with transplanted hepatocyte carcinoma 22 as an in-vivo test model. It was found that 3n center dot HCl could inhibit significantly the growth of tumor, and that this effect was dose-dependent. Meanwhile, the compound 3n center dot HCl showed low toxicity compared with compound 1 center dot HCl as evidenced by the little body-weight loss. These results confirmed that compound 3n center dot HCl is more potent than the lead compound 1 center dot HCl. Preliminary structure-activity relationships indicated that: a) Both nitrile group and the cyclic amine containing at least two nitrogens were indispensable moieties to keep the activity; b) substitution of the piperazine ring is unfavorable for the improvement of activity; c) the suitable linker joining the piperazinyl dithiocarboxyl and diphenylacetonitril group should be ethylene; d) a non-coplanar arrangement of the two benzene rings appears to be essential for activity.

Dithiocarbamic Acid Esters As Anticancer Agent. Part 1: 4-Substituted-piperazine-1-carbodithioic Acid 3-Cyano-3,3-diphenyl-propyl Esters

Synthesis and Structure-Activity Relationships of a Novel Class of Dithiocarbamic Acid Esters As Anticancer Agent.

Discovery of Novel Heteroarylmethylcarbamodithioates As Potent Anticancer Agents: Synthesis, Structure-Activity Relationship Analysis and Biological Evaluation.

Discovery and Optimization of Novel Dual Dithiocarbamates As Potent Anticancer Agents.

SYNTHESIS AND ANTI-TUMOR ACTIVITIES OF 1,4 BIS[3- (AMINO-DITHIOCARBOXY)PROPIONYL] PIPERAZINE DERIVATIVES

Synthesis and in Vitro Anticancer Activity of 6,7-Methylenedioxy (or 5-Hydroxy-6-methoxy)-2-(substituted Selenophenyl)Quinolin-4-One Analogs

Synthesis and Anti-tumor Activities of Novel 18Β-Glycyrrhetinic Acid Derivatives Attaching Dithiocarbamate Units

Synthesis Of Diaryl Ether Substituted Piperazine Derivatives And Their Cytotoxic Activities

Synthesis and Biological Evaluation of Derivatives of 4-Deoxypodophyllotoxin As Antitumor Agents.

Synthesis and Biological Evaluation of Piperazine Group-Linked Bivalent Beta-Carbolines As Potential Antitumor Agents

Design, Synthesis and Cytotoxic Activities of Novel 2,5-Diketopiperazine Derivatives.

Synthesis and anticancer activities of 4-(4-substituted piperazin)-5,6,7-trialkoxy quinazoline derivatives

Design, Synthesis and Anti‐Tumor Activity Evaluation of Novel 3,4‐(methylenedioxy)cinnamic Acid Amide‐Dithiocarbamate Derivatives

Structure-activity Relationships of Novel Dithiocarbamates Containing Α,β-Unsaturated Ketone Fragment As Potent Anticancer Agents

Novel Dithiocarbamic Acid Esters Derived from 6-Aminomethyl-4-anilinoquinazolines and 6-Aminomethyl-4-anilino-3-cyanoquinolines As Potent EGFR Inhibitors.

Synthesis, DNA Intercalation and 3D QSAR Analysis of Cis-2,4,5-trisubstituted-1,3-dithiolanes As a Novel Class of Antitumor Agents.

Synthesis and in Vitro Antitumor Activity of Novel Bivalent Β-Carboline-3-carboxylic Acid Derivatives with DNA As a Potential Target

Synthesis and Antitumor Activities of Piperazine- and Cyclen-Conjugated Dehydroabietylamine Derivatives

Synthesis and Biological Activities of Artemisinin-Piperazine-dithiocarbamate Derivatives

Synthesis and Preliminary Anticancer Evaluation of 4‐C Derivatives of Diphyllin

Synthesis and anti-tumor activity of 1-［bi-(4-fluoroph enyl)-methyl］-4-substituted piperazines Synthesis and anti-tumor activity of 1-［bi-(4-fluoroph enyl)-methyl］-4-substituted piperazines